Products billed under this code include Medrol, Medrol (Pak), Medrol Dosepak, Methylprednisolone, Methylprednisolone (Pak).
Payment limit per 4 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Medrol | Pfizer Inc | 00009-0020-01 | 50 | $6.40 |
| Medrol | Pfizer Inc | 00009-0022-01 | 50 | $6.40 |
| Medrol | Pfizer Inc | 00009-0056-02 | 100 | $12.80 |
| Medrol | Pfizer Inc | 00009-0073-01 | 200 | $25.60 |
| Medrol (Pak) | Pfizer Inc | 00009-0056-04 | 21 | $2.688 |
| Medrol Dosepak | A-S Medication Solutions | 50090-0092-00 | 21 | $2.688 |
| Methylprednisolone | Major Pharmaceuticals | 00904-6914-61 | 100 | $12.80 |
| Methylprednisolone | Mylan Pharmaceuticals Inc. | 59762-0049-01 | 50 | $6.40 |
| Methylprednisolone | Mylan Pharmaceuticals Inc. | 59762-0050-01 | 200 | $25.60 |
| Methylprednisolone | Mylan Pharmaceuticals Inc. | 59762-0051-01 | 200 | $25.60 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Methylprednisolone | Mylan Pharmaceuticals Inc. | 59762-4440-03 | 100 | $12.80 |
| Methylprednisolone | Chartwell | 62135-0760-01 | 100 | $12.80 |
| Methylprednisolone | Chartwell | 62135-0760-21 | 21 | $2.688 |
| Methylprednisolone | Chartwell | 62135-0761-26 | 50 | $6.40 |
| Methylprednisolone | Chartwell | 62135-0762-50 | 200 | $25.60 |
| Methylprednisolone | Chartwell | 62135-0763-26 | 200 | $25.60 |
| Methylprednisolone | BluePoint Laboratories | 68001-0624-01 | 21 | $2.688 |
| Methylprednisolone | American Health Packaging | 68084-0149-01 | 100 | $12.80 |
| Methylprednisolone | Zydus Pharmaceuticals (USA) Inc. | 68382-0916-01 | 100 | $12.80 |
| Methylprednisolone | Zydus Pharmaceuticals (USA) Inc. | 68382-0917-11 | 50 | $6.40 |
| Methylprednisolone | Zydus Pharmaceuticals (USA) Inc. | 68382-0918-18 | 200 | $25.60 |
| Methylprednisolone | Zydus Pharmaceuticals (USA) Inc. | 68382-0919-11 | 200 | $25.60 |
| Methylprednisolone (Pak) | A-S Medication Solutions | 50090-3094-00 | 21 | $2.688 |
| Methylprednisolone (Pak) | A-S Medication Solutions | 50090-3811-00 | 21 | $2.688 |
| Methylprednisolone (Pak) | Mylan Pharmaceuticals Inc. | 59762-4440-02 | 21 | $2.688 |
| Methylprednisolone (Pak) | Zydus Pharmaceuticals (USA) Inc. | 68382-0916-34 | 21 | $2.688 |
| Methylprednisolone (Pak) | Preferred Pharmaceuticals Inc | 68788-7833-02 | 21 | $2.688 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.128 | −$0.032 | 4 MG | Methylprednisolone oral | v1, posted September 17, 2026 |
| 3Q26 | $0.16 | +$0.022 | 4 MG | Methylprednisolone oral | v1, posted September 15, 2026 |
| 2Q26 | $0.138 | −$0.001 | 4 MG | Methylprednisolone oral | v1, posted September 15, 2026 |
| 1Q26 | $0.139 | +$0.031 | 4 MG | Methylprednisolone oral | v1, posted September 15, 2026 |
| 4Q25 | $0.108 | −$0.125 | 4 MG | Methylprednisolone oral | v1, posted September 8, 2026 |
| 3Q25 | $0.233 | −$0.01 | 4 MG | Methylprednisolone oral | v1, posted March 10, 2026 |
| 2Q25 | $0.243 | −$0.004 | 4 MG | Methylprednisolone oral | v1, posted March 10, 2026 |
| 1Q25 | $0.247 | +$0.003 | 4 MG | Methylprednisolone oral | v1, posted December 19, 2025 |
| 4Q24 | $0.244 | +$0.002 | 4 MG | Methylprednisolone oral | v1, posted June 11, 2025 |
| 3Q24 | $0.242 | −$0.003 | 4 MG | Methylprednisolone oral | v1, posted June 11, 2025 |
| 2Q24 | $0.245 | +$0.018 | 4 MG | Methylprednisolone oral | v1, posted March 11, 2025 |
| 1Q24 | $0.227 | −$0.014 | 4 MG | Methylprednisolone oral | v1, posted December 19, 2024 |
| 4Q23 | $0.241 | −$0.02 | 4 MG | Methylprednisolone oral | v1, posted October 10, 2024 |
| 3Q23 | $0.261 | −$0.01 | 4 MG | Methylprednisolone oral | v1, posted June 5, 2024 |
| 2Q23 | $0.271 | +$0.017 | 4 MG | Methylprednisolone oral | v1, posted February 23, 2024 |
| 1Q23 | $0.254 | −$0.02 | 4 MG | Methylprednisolone oral | v1, posted December 6, 2023 |
| 4Q22 | $0.274 | −$0.001 | 4 MG | Methylprednisolone oral | v1, posted June 22, 2023 |
| 3Q22 | $0.275 | +$0.007 | 4 MG | Methylprednisolone oral | v1, posted June 9, 2023 |
| 2Q22 | $0.268 | +$0.016 | 4 MG | Methylprednisolone oral | v1, posted December 14, 2022 |
| 1Q22 | $0.252 | −$0.006 | 4 MG | Methylprednisolone oral | v1, posted June 8, 2022 |
| 4Q21 | $0.258 | −$0.015 | 4 MG | Methylprednisolone oral | v1, posted June 2, 2022 |
| 3Q21 | $0.273 | −$0.021 | 4 MG | Methylprednisolone oral | v1, posted June 2, 2022 |
| 2Q21 | $0.294 | −$0.055 | 4 MG | Methylprednisolone oral | v1, posted March 1, 2022 |
| 1Q21 | $0.349 | – | 4 MG | Methylprednisolone oral | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
